Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001140361-26-035316

Options or other derivatives

  • Principal Financial Officer acquired 33,660 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DelAversano Robert J · Principal Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +33,660 33,660 D
Loading xslF345X06/form4.xml…